Search This Blog

Friday, November 3, 2023

The Boycott Formula: How conservatives can restrain left-wing corporate culture

 Conservatives have recently scored surprise victories against left-wing corporate culture, with successful pressure campaigns against a trio of blue-chip companies—Disney, Target, and Bud Light—that have revealed the potential of a culture-war tactic once considered the Left’s stock-in-trade: the consumer boycott.

The campaigns are notable because they drew blood, figuratively speaking. Disney, which promised to embed radical gender theory in its children’s programming, watched its stock price plummet and signaled a retreat from the culture war. Target, which featured “breast binders” as part of its seasonal “Pride Collection,” saw a decline in sales and promised to “pause, adapt, and learn.” Bud Light featured a transgender “influencer” in an advertising campaign, sending its reputation and sales into freefall.

What lessons can be drawn from these examples? And how can conservatives use boycotts to fight left-wing cultural capture?

To answer these questions, let’s consult the academic literature on consumer boycotts. First, it’s important to understand the genesis—or, in narrative terms, the “inciting incident”—of a potential boycott. Research suggests that in successful boycotts, activists often highlight a firm’s “egregious act,” a transgression of some deeply held value among consumers, and channel the resulting “negative arousal” into a boycott. To expand participation, activists must create a sense that partaking in the boycott provides an opportunity to “make a difference,” change company behavior, and join in a widely shared cause. The research also suggests that boycotts must begin with a sense of optimism, as the “perceived efficacy” of a campaign significantly determines its likelihood of success. 

Next, the mechanics. Northwestern University professor Brayden King collected data from 133 boycott campaigns conducted between 1990 and 2005 and used statistical analysis to identify which tactics are most correlated with success. King argues that boycott campaigns succeed through “market disruption,” targeting a firm’s stock price, and “mediated disruption,” targeting a firm’s public reputation. These two strategies are mutually reinforcing, as economic damage can lead to greater media coverage, and greater media coverage of a company’s difficulties can lead to economic damage.

King’s paper proposes that boycott leaders consider two factors: target selection and activist tactics. The data from King’s study suggest that the ideal target is a large company with a high-status reputation and, to a lesser extent, one without access to “slack resources”—what another scholar defines as “actual or potential resources which allow an organization to adapt successfully to internal pressures for adjustment or to external pressures for change in policy.” Disney, Target, and Bud Light all fit this bill. Each is a large company with a carefully cultivated public reputation, and each was somewhat vulnerable economically: Disney has had ongoing financial problems, Target operates on razor-thin margins, and Bud Light is easily substituted with other products. Associating those firms with gender theory, breast binders, and transgender activism, respectively, stood in stark contrast with each firm’s status quo ante, creating the opportunity for a reversal and a successful boycott.

On the activist side, research suggests that the most important determinant of a successful boycott is driving sustained media coverage, with celebrity endorsements and public demonstrations providing effective multipliers for this form of “mediated disruption.” The data also indicate an additional benefit to having a large, professionally staffed activist organization lead the boycott. These “social movement organizations,” which have proliferated on the left, help garner media coverage, recruit high-profile allies, pressure corporate executives, and orchestrate on-the-ground protests to create additional leverage. Conservatives have not yet established effective pressure groups, but even decentralized social-media activists can force a firm into a negative financial and media cycle, such as happened to Bud Light, which suffered a $400 million decline in revenues following its transgender controversy.

The good news is that conservatives have a promising method for restraining left-wing corporate culture. The recent boycott campaigns against Disney, Target, and Bud Light demonstrate that aligning social-media activists with mass-market outlets, most importantly Fox News and The Daily Wire, can shape public perceptions and convert a firm’s “egregious act” into significant financial and reputational damage. Moving forward, conservatives need to develop professional activist organizations to formalize, direct, and sustain “protracted siege” campaigns against recalcitrant corporations. This combination—social-media agitation, mass-media amplification, and formalized pressure groups—has the potential to be enormously effective.

Conservatives face challenges. First, they must organize. Nonprofits such as the New Tolerance Campaign, American Principles Project, and Consumers’ Research are starting to build the infrastructure for corporate-pressure campaigns, but more needs to be done. Conservatives also must discover whether corporate commitments to critical race theory, gender ideology, and “diversity, equity, and inclusion” are superficial or deeply held. The basic formula for determining a boycott’s success is whether “economic pressure” and “image pressure” are stronger than a firm’s “policy commitment.”

In the years ahead, conservatives will be able to measure these forces more accurately. If American companies are using left-wing ideology for cynical and fleeting purposes, conservatives could continue to secure victories in the corporate sphere. If, on the other hand, corporations are authentically committed to left-wing cultural ideology, and these commitments are cemented in corporate life through countervailing pressure, bureaucratic necessity, and civil-rights law, conservatives will need to fight even harder to tip the scales.

Biden’s Election Gimmick Undercut National Security

 The chaotic turn of events around the globe in the past weeks has shown that history repeats itself.

Fifty years ago when the Yom Kippur War raged in the Middle East, Americans felt the pinch as oil-rich countries blocked U.S. imports of their crude in response to U.S. support of Israel. Now, the atrocious tragedies committed by barbaric Hamas terrorists are again causing chaos and strife in the Middle East.

Because of planning in the 1970s and under the right leadership today, this conflict shouldn’t spark concerns about gas prices for Americans as we learned our lesson a half-century ago and created the Strategic Petroleum Reserve. Unfortunately, President Biden disregarded these lessons to score cheap political points at the expense of the American consumer and our national security.

The week of January 20, 2021, when President Biden was sworn into office the national average for a gallon of gas was just under $2.40. That means a family with a minivan could easily fill up their tank for under $50.

Then Biden’s anti-energy independence agenda kicked in. He made it clear that he wanted to “end fossil fuel” during his campaign and got right to work on day one to implement his devastating plan. He ended the Keystone XL Pipeline, proposed tax increases on oil and gas companies and pushed policies that benefited “green” energy and Chinese companies over reliable American energy.

By the time Vladimir Putin invaded Ukraine in February of 2022, Biden’s policies had already pushed the national weekly average to $3.53. Biden – desperate to hide his failed policies – quickly blamed the high cost of gas on the invasion, despite the fact that under a year of his policies prices had already increased by more than a dollar per gallon.

With the Russian invasion pushing prices even higher in an election year, Biden decided to act.

No, he didn’t reverse his anti-American energy policies – that would have been the right long-term solution. Instead, he traded in our safety net of the Strategic Petroleum Reserve to save a few votes. In spite of the SPR gimmick, prices are still averaging around $3.53, so filling up that minivan now costs close to $70 – and our country’s safety.

The Strategic Petroleum Reserve is a national security asset. When full, it prevents the U.S. from being subject to global crises that could limit the availability of crude oil or the whims of our adversaries who may wish to punish us by withholding exports.

The idea was supported by multiple presidential administrations like Harry Truman and Dwight D. Eisenhower in the middle of the 20th century, but it wasn’t until OPEC’s oil embargo of 1973-74 that the need was greatly recognized. President Gerald Ford eventually signed the Energy Policy and Conservation Act into law in December 1975.

Nearly 50 years after its creation the SPR is at its lowest level since 1984. And it couldn’t come at a more perilous time in our world.

Establishing the SPR was a way for us to safeguard against OPEC’s impulses and to reduce our dependence on foreign countries should there be a global conflict – but here we are again facing a crisis in the Middle East.

Now would be a good time to have a robust Strategic Petroleum Reserve on which to rely.

The right thing to do – after two years of fruitlessly doing the wrong thing – would be to replenish the SPR, and fast. But the Biden administration has abandoned this responsibility. The whole intention was to have SPR as a backstop, but President Biden threw that away for a political gimmick.

Last October, the White House announced that it would implement a “first-of-its-kind rule” establishing a system of fixed-rate price contracts for replenishing the SPR. Per the administration’s policy, they intend to purchase “crude oil for the SPR when prices are at or below about $67 to $72 per barrel.” The administration’s logic was that the Department of Energy should get a preferred rate when buying for the SPR, well below what the public market was bearing.

This untested fixed-price bid system imposed by the White House has allowed the administration to ignore its responsibility to resupply the SPR to the detriment of the U.S.’ economic and national security.

In January of this year, the DOE rejected bids from several producers to refill the SPR because the market rate for crude oil at the time was well above the administration’s arbitrary fixed price. And again in mid-October, the DOE announced they would not refill the SPR at a competitive level, instead wanting to pay $79 a barrel when the current market price is about $86 a barrel.

The misaligned economics of this system is straightforward – if producers get a better rate in the market than what DOE is prepared to pay, the SPR will remain at record lows – making our nation less safe and prepared.

I’ve offered legislation – the Strategic Petroleum Reserve Replenishment Act – in this Congress and the last that would correct this issue. The House also passed a similar amendment I introduced that was included in H.R. 1 – the Lower Energy Costs Act. It would require DOE to use index-based pricing when accepting bids for the SPR. This method will ensure that DOE accepts bids at the market rate for crude oil rather than Biden’s price-fixing scheme. Unfortunately, the Democrat-led Senate has yet to take action on the bill.

Our world is less safe today than in January 2021, and we are less prepared to withstand foreign adversaries using oil as leverage. Biden should have never put our national defense in jeopardy just to try and eke out a few more midterm votes. Now that it’s depleted, his administration should really be working to replenish the Strategic Petroleum Reserve – back to where it was on January 20, 2021, when a full SPR provided us with extra protection and a full tank of gas was $20 bucks cheaper.

 

Ron Estes, one of only a handful of engineers in Congress, worked in the aerospace, energy and manufacturing sectors before representing Kansas’ 4th Congressional District since 2017. He is a fifth-generation Kansan, former state treasurer, and serves on the House Committee on Ways and Means, Budget Committee, and Education and the Workforce Committee. 

https://www.realclearenergy.org/articles/2023/11/02/bidens_election_gimmick_undercut_national_security_990301.html

The pharmacists who revealed the myth of 'decongestants'

 Sixteen years after pharmacists from the University of Florida College of Pharmacy in Gainesville petitioned the FDA to require new efficacy studies of an ingredient in decongestants, their efforts came to fruition. In September, an FDA panel unanimously declared the ingredient ineffective. 

Oral phenylephrine — often found in drugs like Sudafed — was first approved as a decongestant in 1976, but since then data has revealed it is much less effective than initially thought. 

So in 2007, Leslie Hendeles, PharmD, and Randy Hatton, PharmD, from UF's College of Pharmacy petitioned the FDA. The agency did recommend further safety and efficacy studies of the ingredient, but they note in an Oct. 27 news release from the American Society of Health-System Pharmacists, that at the time it did not appear the agency prioritized the matter. 

A 2015 study that "showed that four times the maximum FDA-approved dose of phenylephrine was no different than placebo," Dr. Hendeles said, prompted a citizen petition to the agency requesting the removal of oral phenylephrine from FDA monographs. That too fell short of leading to a formal change by the federal agency.

However, it did lead to further research led by the Nonprescription Drug Advisory Committee in September, which found that the ingredient was not effective orally, only when administered via the nasal cavity. This ultimately drove the FDA's recent decision. 

The advisory committee, after reviewing all of the evidence, voted unanimously to validate what we first said nearly 20 years ago," Dr. Hatton stated in the release.

The two pharmacists noted that other drugs that may be ineffective are still on the market, like guaifenesin — an ingredient in products like Mucinex — but their decades-long work in at least one area has finally been realized. 

https://www.beckershospitalreview.com/pharmacy/the-pharmacists-who-revealed-the-myth-of-decongestants.html

Classification of four stages of heart attack based on heart muscle damage

 Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI) appearing in the Canadian Journal of Cardiology, published by Elsevier, presents a four-stage classification of heart attack based on heart muscle damage. This work by a group of noted experts has the potential to stratify risk more accurately in heart attack patients and lays the groundwork for development of new, injury-stage-specific and tissue pathology-based therapies.

Lead author Andreas Kumar, MD, MSc, Northern Ontario School of Medicine University, and Department of Cardiovascular Sciences, Health Sciences North, Sudbury, ON, Canada, explains: "MI remains a leading cause of morbidity and mortality. Existing tools classify MIs using a patient's clinical presentation and/or the cause of the heart attack, as well as ECG findings. Although these tools are very helpful to guide treatment, they do not consider details of the underlying tissue damage caused by the heart attack. This expert consensus, based on decades of data, is the first classification system of its kind ever released in Canada and internationally. It offers a more differentiated definition of heart attacks and improves our understanding of acute atherothrombotic MI. On a tissue level, not all heart attacks are the same; the new CCS-AMI classification paves the way for development of more refined therapies for MI, which could ultimately result in better patient clinical care and improved survival rates."

The CCS-AMI classification describes damage to the heart muscle following an MI in four sequential and progressively severe stages. Each stage reflects progression of tissue pathology of myocardial ischemia and reperfusion injury from the previous stage. It is based on a strong body of evidence about the effect an MI has on the heart muscle.

As damage to the heart increases through each progressive CCS-AMI stage, patients have dramatically increased risk of complications such as arrhythmia, heart failure, and death. Appropriate therapy can potentially stop injury from progressing and halt the damage at an earlier stage.

  • Stage 1: Aborted MI (no/minimal myocardial necrosis). No or minimal damage to the heart muscle. In the best case the entire area of myocardium at risk may be salvaged.
  • Stage 2: MI with significant cardiomyocyte necrosis, but without microvascular injury. Damage to the heart muscle and no injury to small blood vessels in the heart. Revascularization therapy will result in restoration of normal coronary flow.
  • Stage 3: MI with cardiomyocyte necrosis and microvascular dysfunction leading to microvascular obstruction (i.e., "no-reflow"). Damage to the heart muscle and blockage of small blood vessels in the heart. The major adverse cardiac event rate is increased 2- to 4-fold at long-term follow-up.
  • Stage 4: MI with cardiomyocyte and microvascular necrosis leading to reperfusion hemorrhage. Damage to the heart muscle, blockage and rupture of small blood vessels resulting in bleeding into the heart muscle. This is a more severe form of microvascular injury, and the most severe form of ischemia-reperfusion injury. It is associated with a further increase in adverse cardiac event rate of 2- to 6-fold at long-term follow-up.

Dr. Kumar concludes: The new classification will help differentiate heart attacks according to the stage of tissue damage and allow healthcare providers to estimate a patient's risk more precisely for arrhythmia, heart failure, and death. The CCS-AMI is ultimately expected to lead to better care, better recovery, and better survival rates for heart attack patients."

In an accompanying editorial, Prakriti Gaba, MD, Brigham and Women's Hospital, Harvard Medical School, and Deepak L. Bhatt, MD, MPH, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, comment: "Kumar et al. present a novel and intriguing four-tiered classification scheme of patients with acute MI. This allows unique utilization of prognostic pathologic features to help distinguish between high and low risk acute MI patients. Greater access to cardiovascular magnetic resonance would be needed to implement this new clinical approach broadly, however, for research on emerging diagnostic and therapeutic strategies, it could be implemented immediately."


Journal Reference:

  1. Andreas Kumar, Kim Connelly, Keyur Vora, Kevin R. Bainey, Andrew Howarth, Jonathon Leipsic, Suzanne Betteridge-LeBlanc, Frank S. Prato, Howard Leong-Poi, Anthony Main, Rony Atoui, Jacqueline Saw, Eric Larose, Michelle M. Graham, Marc Ruel, Rohan Dharmakumar. The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus StatementCanadian Journal of Cardiology, 2023; DOI: 10.1016/j.cjca.2023.09.020   

Combining cell types may lead to improved cardiac cell therapy following heart attack

 Researchers at the University of Wisconsin-Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged heart muscle.

The study, published in Circulation -- which addresses major challenges of using heart muscle cells, called cardiomyocytes, grown from stem cells -- takes a crucial step toward future clinical applications.

Previous research has shown that transplanting cardiomyocytes made from induced pluripotent stem cells (iPSC) can replace muscle in the hearts of mammals. Researchers have struggled to bring the treatment to the clinic, in part because the implanted cells haven't developed enough life-sustaining blood vessels to survive very long.

The new study confronted that challenge by combining the lab-grown cardiomyocytes with stem-cell-derived endothelial cells -- the cells that line blood. The combination therapy also holds promise for tackling arrhythmia, another significant obstacle in heart regeneration with stem-cell-derived cardiomyocytes.

"Our findings suggest that human iPSC-derived endothelial cells can effectively augment the remuscularization of the heart by iPSC-derived cardiomyocytes, offering a promising avenue for future clinical applications," says Patrick Hsieh, a researcher with Academia Sinica's Institute of Biomedical Sciences who conducted the study while working as a visiting professor at the UW-Madison Stem Cell & Regenerative Medicine Center.

Hsieh and study lead author Yu-Che Cheng collaborated with Tim Kamp, who serves as director of the Stem Cell & Regenerative Medicine Center, as well as a team of researchers at UW-Madison and the Wisconsin National Primate Research Center, to examine the therapeutic effect of co-transplantation in mice and non-human primates undergoing a heart attack.

"The main advantage of iPSCs is their ability to be differentiated into many types of cells and serve as a valuable resource for cell therapy," says Cheng, who is a project manager at Academia Sinica. "In this study, we generated billions of endothelial cells and cardiomyocytes from the same iPSCs line to inject into mice and non-human primates."

"The simple idea of the project was to enhance blood flow and promote survival of iPSC-cardiomyocytes using blood vessel-forming endothelial cells," Kamp says. "But the reality of generating the optimal cell preparations followed by precise delivery to the heart reflects tremendous effort by an international team of collaborators."

The team would like to conduct further studies to refine their cell transplantation protocols and assess long-term safety and efficacy. Promising results, Hsieh believes, would lead to clinical trials with human patients with heart disease, a leading cause of death around the world.

"As a cardiac surgeon now focusing on translational research, the most exciting aspect of this research is the potential to make a meaningful impact on the treatment of heart disease," Hsieh says. "Witnessing the significant improvements in cardiac function and tissue regeneration resulting from our combined cell therapy approach is both inspiring and promising for the future of cardiovascular medicine."

This research was supported by grants from the Ministry of Science and Technology, Taiwan (111-2321-B-001-012, 111-2740-B-001-003, 110-2320-B-001-023), National Health Research Institutes (EX111-10907SI), U.S. National Academy of Medicine and Academia Sinica (AS-HLGC-109-05), National Institutes of Health (U01HL134764 and UL1TR002373) and the National Science Foundation (EEC-1648035).

Journal Reference:

  1. Yu-Che Cheng, Marvin L. Hsieh, Chen-Ju Lin, Cindy M.C. Chang, Ching-Ying Huang, Riley Puntney, Amy Wu Moy, Chien-Yu Ting, Darien Zhing Herr Chan, Martin W. Nicholson, Po-Ju Lin, Hung-Chih Chen, Gina C. Kim, Jianhua Zhang, Jennifer Coonen, Puja Basu, Heather A. Simmons, Yen-Wen Liu, Timothy A. Hacker, Timothy J. Kamp, Patrick C.H. Hsieh. Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human PrimatesCirculation, 2023; 148 (18): 1395 DOI: 10.1161/CIRCULATIONAHA.122.061736

Seeing the unseen: How butterflies can help scientists detect cancer

 There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth's magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower frequencies than humans can. Butterflies can perceive a broader range of colors, including ultraviolet (UV) light.

Inspired by the enhanced visual system of the Papilio xuthus butterfly, a team of researchers have developed an imaging sensor capable of "seeing" into the UV range inaccessible to human eyes. The design of the sensor uses stacked photodiodes and perovskite nanocrystals (PNCs) capable of imaging different wavelengths in the UV range. Using the spectral signatures of biomedical markers, such as amino acids, this new imaging technology is even capable of differentiating between cancer cells and normal cells with 99% confidence.

This new research, led by University of Illinois Urbana-Champaign electrical and computer engineering professor Viktor Gruev and bioengineering professor Shuming Nie, was recently published in the journal Science Advances.

Small Variations

"We've taken inspiration from the visual system of butterflies, who are able to perceive multiple regions in the UV spectrum, and designed a camera that replicates that functionality," Gruev says. "We did this by using novel perovskite nanocrystals, combined with silicon imaging technology, and this new camera technology can detect multiple UV regions."

UV light is electromagnetic radiation with wavelengths shorter than that of visible light (but longer than x-rays). We are most familiar with UV radiation from the sun and the dangers it poses to human health. UV light is categorized into three different regions -- UVA, UVB and UVC -- based on different wavelength ranges. Because humans cannot see UV light, it is challenging to capture UV information, especially discerning the small differences between each region.

Butterflies, however, can see these small variations in the UV spectrum, like humans can see shades of blue and green. Gruev notes, "It is intriguing to me how they are able to see those small variations. UV light is incredibly difficult to capture, it just gets absorbed by everything, and butterflies have managed to do it extremely well."

The Imitation Game

Humans have trichromatic vision with three photoreceptors, where every color perceived can be made from a combination of red, green and blue. Butterflies, however, have compound eyes, with six (or more) photoreceptor classes with distinct spectral sensitivities. In particular, the Papilio xuthus, a yellow, Asian swallowtail butterfly, has not only blue, green and red, but also violet, ultraviolet and broadband receptors. Further, butterflies have fluorescent pigments that allow them to convert UV light into visible light which can then be easily sensed by their photoreceptors. This allows them to perceive a broader range of colors and details in their environment.

Beyond the increased number of photoreceptors, butterflies also exhibit a unique tiered structure in their photoreceptors. To replicate the UV sensing mechanism of the Papilio xuthus butterfly, the UIUC team has emulated the process by combining a thin layer of PNCs with a tiered array of silicon photodiodes.

PNCs are a class of semiconductor nanocrystals that display unique properties similar to that of quantum dots -- changing the size and composition of the particle changes the absorption and emission properties of the material. In the last few years, PNCs have emerged as an interesting material for different sensing applications, such as solar cells and LEDs. PNCs are extremely good at detecting UV (and even lower) wavelengths that traditional silicon detectors are not. In the new imaging sensor, the PNC layer is able to absorb UV photons and re-emit light in the visible (green) spectrum which is then detected by the tiered silicon photodiodes. Processing of these signals allows for mapping and identification of UV signatures.

Healthcare and Beyond

There are various biomedical markers present in cancerous tissues at higher concentrations than in healthy tissues -- amino acids (building blocks of proteins), proteins, and enzymes. When excited with UV light, these markers light up and fluoresce in the UV and part of the visible spectrum, in a process called autofluorescence. "Imaging in the UV region has been limited and I would say that has been the biggest roadblock for making scientific progress," explains Nie. "Now we have come up with this technology where we can image UV light with high sensitivity and can also distinguish small wavelength differences."

Because cancer and healthy cells have different concentrations of markers and therefore different spectral signatures, the two classes of cells can be differentiated based on their fluorescence in the UV spectrum. The team evaluated their imaging device on its ability to discriminate cancer-related markers and found that is capable of differentiating between cancer and healthy cells with 99% confidence.

Gruev, Nie and their collaborative research team envision being able to use this sensor during surgery. One of the biggest challenges is knowing how much tissue to remove to ensure clear margins and such a sensor can help facilitate the decision-making process when a surgeon is removing a cancerous tumor.

"This new imaging technology is enabling us to differentiate cancerous versus healthy cells and is opening up new and exciting applications beyond just health," Nie says. There are many other species besides butterflies capable of seeing in the UV, and having a way to detect that light will provide interesting opportunities for biologists to learn more about these species, such as their hunting and mating habits. Bringing the sensor underwater can help bring a greater understanding of that environment as well. While a lot of UV is absorbed by water, there is still enough that makes it through to have an impact and there are many animals underwater that also see and use UV light.

Journal Reference:

  1. Cheng Chen, Ziwen Wang, Jiajing Wu, Zhengtao Deng, Tao Zhang, Zhongmin Zhu, Yifei Jin, Benjamin Lew, Indrajit Srivastava, Zuodong Liang, Shuming Nie, Viktor Gruev. Bioinspired, vertically stacked, and perovskite nanocrystal–enhanced CMOS imaging sensors for resolving UV spectral signaturesScience Advances, 2023; 9 (44) DOI: 10.1126/sciadv.adk3860

The Non-Citizen Voting Scam

 by Betsy McCaughey via The Epoch Times,

If you think offering migrants luxury hotel rooms, free meals, laundry service, transportation, health care, and immigration lawyers is excessive, just wait until they can vote.

Democrats are pushing to allow noncitizens to vote in local elections in New York City, Boston, and other municipalities, and statewide in Connecticut.

The number of migrants pouring across the southern border has hit a record high, according to data released on Oct. 21. Illegal immigrant crossings soared 21 percent over the previous month. On a yearly basis, the figure hit 2.48 million.

Democrats may feign shock and distress. Don’t be fooled. Democrats see these newcomers as their guarantee of a permanent voting majority in local elections. Not years from now, after the newcomers become citizens. Right now.

New York Mayor Eric Adams’s rhetoric is typical. He warns that the overwhelming number of migrants arriving—currently 16,000 to 17,000 a month—“will destroy New York City,” but he’s also leading the legal effort to turn migrants into voters.

Mr. Adams and other New York Democrats pushed President Joe Biden to expedite work authorizations for them. They said it’s about making migrants self-sufficient. Maybe, but Democrats have another powerful motive.

If you read the fine print of New York City’s “Our City, Our Vote” law, enacted in December 2021, it says that anyone with a work authorization who has been in the city for a mere 30 days can vote, even if they entered the country illegally.

President Biden’s recent action fast-tracking work authorizations for Venezuelan border crossers, who make up about 41 percent of recent arrivals in New York City, will make tens of thousands of them eligible to vote under New York City’s new law, as soon as they obtain their working papers.

That is, if New York City’s voting law is allowed to go into effect—a big “if.” The law is tied up in court.

A group of Republicans led by Staten Island Borough President Vito Fossella sued, arguing the state constitution grants the right to vote to “every citizen.” A Staten Island judge bought that argument and struck down the law, but Mr. Adams’s law department is appealing that ruling in a higher court, arguing that the state constitution does not specifically prohibit noncitizens from voting.

Mr. Adams has a shot at winning. Vermont’s top court ruled in favor of allowing noncitizens to vote in municipal elections, even though the Vermont constitution restricts voting in state elections to U.S. citizens.

California and Maryland also already permit municipalities to enfranchise noncitizens.

The Boston City Council is debating allowing newcomers to vote, including migrants who recently came across the border illegally and have temporary protected status.

In Washington, D.C., Democrats rammed through a local law in November 2022 allowing noncitizens, even foreign embassy employees, to vote, as long as they’ve resided in the city for 30 days.

In Connecticut, Democrats want to amend the state’s constitution to allow noncitizens to vote in state and local elections. Amending the state’s charter is a multiyear complicated process, and it’s facing stiff opposition from the Republican minority in the Legislature. House Minority Leader Rep. Vincent Candelora called noncitizen voting “outrageous.”

For New York City, “suicidal” is more accurate.

Adding some 800,000 noncitizens to the 5 million registered voters in the city will have an effect, even if newcomers don’t always vote as a block.

Nora Moran of the United Neighborhood Houses, a New York nonprofit, predicted that noncitizen voting will make political leaders “more responsive” to the needs of newcomers and their neighborhoods.

To the extent “more responsive” means spending more, that will be a disaster.

City spending on migrants already exceeds the budgets of the fire, sanitation, and parks departments combined.

“We are past our breaking point,” Mr. Adams cautioned two months ago, adding that New Yorkers will be facing cuts in every type of city service to foot the bill.

Letting noncitizens vote will dilute the political power of all other New Yorkers, who are the real victims of President Biden’s open borders.

Tell Mr. Adams to withdraw his legal appeal and stop pushing for noncitizen voting.

Voting is a privilege reserved for citizens. Once immigrants follow the law, become naturalized, and swear loyalty to this nation and its Constitution, they should be entitled to vote. Not before.

https://www.zerohedge.com/political/non-citizen-voting-scam